https://www.selleckchem.com/pr....oducts/Fedratinib-SA
The objective of our study was to analyze quality of life (QOL) in an e-cohort of patients treated for breast cancer (BC) by endocrine therapy (ET), by means of validated quality of life questionnaires. A retrospective, observational, e-cohort study was conducted (Seintinelles platform). Female patients treated for nonmetastatic and nonrecurrent BC, treated in France after 2005, filled in online questionnaires concerning QOL (QLQ-C30 and QLQ-BR23), tolerability of treatment and demographic characteristics. A multiv
Like
Comment
Share
